Urinary exosomal WT-1 levels were also significantly lower in patients in remission from either FSGS or steroid-sensitive nephrotic syndrome, or after steroid treatment in six steroid-sensitive nephrotic syndrome patients [160]. This evidence concerns the gene WT1 and focal segmental glomerulosclerosis.